Jia Luo
Thoracic Medical Oncologist and Instructor in Medicine Dana-Farber Cancer Institute, Harvard Medical School
Seminars
Thursday 18th September 2025
Spotlighting Alternative Clinical Trial Designs to Improve Evaluation of RAS-Targeting Therapies Leading to Accelerated Approvals
4:00 pm
- How to create alternative clinical trial designs to better assess efficacy and reduce traditional barriers
- Uncovering lessons from past trials and using them to inform future clinical trials for KRAS inhibitorsÂ
- Highlighting the importance of considering additional mutations beyond KRAS to predict treatment responses
Thursday 18th September 2025
Roundtable Discussion: Tackling Clinical Roadblocks & Pharmacokinetic Challenges to Supercharge Translation into the Clinic & Fast-Track Therapeutics to the Patients
3:30 pm
- What are the major roadblocks hindering the transition from preclinic into the clinic?
- How to bridge the gap between preclinical testing strategies and clinical settings to achieve more clinical successes
- How to enhance pharmacokinetic profiles of RAS inhibitors for accelerating translation into the clinic
